Characterization of cardiac dysfunction in sepsis: An ongoing challenge

Shock

Volumn 41, Issue 1, 2014, Pages 12-24

  Zaky, Ahmed ^a   Deem, Steven ^a   Bendjelid, Karim ^b   Treggiari, Miriam M ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

cardiomyopathy; echocardiography; mechanisms; myocardial dysfunction; Septic shock; toll like receptors

Indexed keywords

CALCIUM; HEAT SHOCK PROTEIN; MATRIX METALLOPROTEINASE; NITRIC OXIDE; TOLL LIKE RECEPTOR;

APOPTOSIS; AUTONOMIC DYSFUNCTION; CALCIUM CELL LEVEL; CLINICAL EVALUATION; DIASTOLIC DYSFUNCTION; ENDOTHELIAL DYSFUNCTION; HEART AFTERLOAD; HEART DISEASE; HEART FUNCTION; HEART MUSCLE INJURY; HEART OUTPUT; HEART VENTRICLE PERFORMANCE; HEMODYNAMICS; HUMAN; MICROORGANISM; NONHUMAN; PERIPHERAL CIRCULATION; REVIEW; SEPSIS; SEPSIS INDUCED CARDIOMYOPATHY; SEPTIC SHOCK;

ANIMALS; BIOLOGICAL MARKERS; CARDIOMYOPATHIES; CORONARY CIRCULATION; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; HUMANS; MYOCARDIAL CONTRACTION; SHOCK, SEPTIC;

EID: 84891588117     PISSN: 10732322     EISSN: 15400514     Source Type: Journal    
DOI: 10.1097/SHK.0000000000000065     Document Type: Review

References (108)

1. Annane D, Bellissant E, Cavaillon JM: Septic shock. Lancet 365(9453): 63-78, 2005.
2. Martin GS, Mannino DM, Eaton S, Moss M: The epidemiology of sepsis in the United States from 1979 through 2000. N Engl JMed 348(16):1546-1554, 2003.
3. Charpentier J, Luyt CE, Fulla Y, Vinsonneau C, Cariou A, Grabar S, Dhainaut JF, Mira JP, Chiche J: Brain natriuretic peptide: a marker of myocardial dysfunction and prognosis during severe sepsis. Crit Care Med 32(3):660-665, 2004.
4. Blanco J: Incidence, organ dysfunction and mortality in severe sepsis: a Spanish multicentre study. Crit Care 12(6):R158, 2008.
5. Brutsaert DL: Cardiac dysfunction in heart failure: the cardiologist's love affair with time. Prog Cardiovasc Dis 49(3):157-181, 2006.
6. Guarracino F, Baldassarri R, Pinsky MR: Ventriculo-arterial decoupling in acutely altered hemodynamic states. Crit Care 17(2), 2013.
7. MacLean LD, Mulligan WG, McLean AP, Duff JH: Patterns of septic shock in manVa detailed study of 56 patients. Ann Surg 166(4):543-562, 1967.
8. Clowes GH Jr, Vucinic M, Weidner MG: Circulatory and metabolic alterations associated with survival or death in peritonitis: clinical analysis of 25 cases. Ann Surg 163(6):866-885, 1966.
9. Packman MI, Rackow EC: Optimum left heart filling pressure during fluid resuscitation of patients with hypovolemic and septic shock. Crit Care Med 11(3):165-169, 1983.
10. Parker MM, Shelhamer JH, Natanson C, Alling DW, Parrillo JE: Serial cardiovascular variables in survivors and nonsurvivors of human septic shock: heart rate as an early predictor of prognosis. Crit Care Med 15(10):923-929, 1987.
11. Wilson RF, Chiscano AD, Quadros E, Tarver M: Some observations on 132 patients with septic shock. Anesth Analg 46(6):751-763, 1967.
12. Michard F, Teboul JL: Predicting fluid responsiveness in ICU patients: a critical analysis of the evidence. Chest 121(6):2000-2008, 2002.
13. Jardin F, Valtier B, Beauchet A, Dubourg O, Bourdarias JP: Invasive monitoring combined with two-dimensional echocardiographic study in septic shock. Intensive Care Med 20(8):550-554, 1994.
14. Weisel RD, Vito L, Dennis RC, Valeri CR, Hechtman HB: Myocardial depression during sepsis. Am J Surg 133(4):512-521, 1977.
15. Parker MM, Shelhamer JH, Bacharach SL, Green MV, Natanson C, Frederick TM, Damske BA, Parrillo JE: Profound but reversible myocardial depression in patients with septic shock. Ann Intern Med 100(4):483-490, 1984.
16. Parrillo JE: Pathogenetic mechanisms of septic shock. N Engl J Med 328(20): 1471-1477, 1993.
17. Parker MM, McCarthy KE, Ognibene FP, Parrillo JE: Right ventricular dysfunction and dilatation, similar to left ventricular changes, characterize the cardiac depression of septic shock in humans. Chest 97(1):126-131, 1990.
18. Vieillard Baron A, Schmitt JM, Beauchet A, Augarde R, Prin S, Page B, Jardin F: Early preload adaptation in septic shock? A transesophageal echocardiographic study. Anesthesiology 94(3):400-406, 2001.
19. Bendjelid K, Suter PM: Does early preload adaptation exist in patients with septic shock? Anesthesiology 95(6):1535, 2001.
20. Etchecopar-Chevreuil C, François B, Clavel M, Pichon N, Gastinne H, Vignon P: Cardiac morphological and functional changes during early septic shock: a transesophageal echocardiographic study. Intensive Care Med 34(2):250-256, 2008.
21. Bouhemad B, Nicolas-Robin A, Arbelot C, Arthaud M, Féger F, Rouby JJ: Acute left ventricular dilatation and shock-induced myocardial dysfunction. Crit Care Med 37(2):441-447, 2009.
22. Bouhemad B, Nicolas-Robin A, Arbelot C, Arthaud M, Féger F, Rouby JJ: Isolated and reversible impairment of ventricular relaxation in patients with septic shock. Crit Care Med 36(3):766-774, 2008.
23. Huang SJ, Nalos M, McLean AS: Is early ventricular dysfunction or dilatation associated with lower mortality rate in adult severe sepsis and septic shock? A meta-analysis. Crit Care 17(3):R96, 2013.
24. Bryg RJ, Pearson AC, Williams GA, Labovitz AJ: Left ventricular systolic and diastolic flow abnormalities determined by Doppler echocardiography in obstructive hypertrophic cardiomyopathy. Am J Cardiol 59(9):925-931, 1987.
25. Garcia MJ, Thomas JD, Klein AL: New Doppler echocardiographic applications for the study of diastolic function. J Am Coll Cardiol 32(4):865-875, 1998.
26. Paulus WJ: How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur Heart J 28(20):2539-2550, 2007.
27. Ikonomidis I: Association of left ventricular diastolic dysfunction with elevated NT-pro-BNP in general intensive care unit patients with preserved ejection fraction: a complementary role of tissue Doppler imaging parameters and NTpro-BNP levels for adverse outcome. Shock 33(2):141-148, 2010.
28. Landesberg G: Diastolic dysfunction and mortality in severe sepsis and septic shock. Eur Heart J 33(7):895-903, 2012.
29. Bruch C, Gradaus R, Gunia S, Breithardt G, Wichter T: Doppler tissue analysis of mitral annular velocities: evidence for systolic abnormalities in patients with diastolic heart failure. J Am Soc Echocardiogr 16(10):1031-1036, 2003.
30. De Keulenaer GW, Brutsaert DL: Systolic and diastolic heart failure: different phenotypes of the same disease? Eur J Heart Fail 9(2):136-143, 2007.
31. Robotham JL, Takata M, Berman M, Harasawa Y: Ejection fraction revisited. Anesthesiology 74(1):172-183, 1991.
32. Celebi AS, Yalcin H, Yalcin F: Current cardiac imaging techniques for detection of left ventricular mass. Cardiovasc Ultrasound 8:19, 2010.
33. Dorosz JL, Lezotte DC, Weitzenkamp DA, Allen LA, Salcedo EE: Performance of 3-dimensional echocardiography in measuring left ventricular volumes and ejection fraction: a systematic review and meta-analysis. J Am Coll Cardiol 59(20):1799-1808, 2012.
34. Stoddard MF, Liddell NE, Vogel RL, Longaker RA, Dawkins PR: Comparison of cardiac dimensions by transesophageal and transthoracic echocardiography. Am Heart J 124(3):675-678, 1992.
35. Leong DP, De Pasquale CG, Selvanayagam JB: Heart failure with normal ejection fraction: the complementary roles of echocardiography and CMR imaging. JACC Cardiovasc Imaging 3(4):409-420, 2010.
36. Biswas M, Sudhakar S, Nanda NC, Buckberg G, Pradhan M, Roomi AU, Gorissen W, Houle H: Two-and three-dimensional speckle tracking echocardiography: clinical applications and future directions. Echocardiography 30(1): 88-105, 2013.
37. Peters J, Mack GW, Lister G: The importance of the peripheral circulation in critical illnesses. Intensive Care Med 27(9):1446-1458, 2001.
38. Cunnion RE, Schaer GL, Parker MM, Natanson C, Parrillo JE: The coronary circulation in human septic shock. Circulation 73(4):637-644, 1986.
39. Takasu O: Mechanisms of cardiac and renal dysfunction in patients dying of sepsis. Am J Respir Crit Care Med 187(5):509-517, 2013.
40. Zhou M, Wang P, Chaudry IH: Cardiac contractility and structure are not significantly compromised even during the late, hypodynamic stage of sepsis. Shock 9(5):352-358, 1998.
41. ver Elst KM, Spapen HD, Nguyen DN, Garbar C, Huyghens LP, Gorus FK: Cardiac troponins I and T are biological markers of left ventricular dysfunction in septic shock. Clin Chem 46(5):650-657, 2000.
42. Mehta NJ: Cardiac troponin I predicts myocardial dysfunction and adverse outcome in septic shock. Int J Cardiol 95(1):13-17, 2004.
43. Wu AH: Increased troponin in patients with sepsis and septic shock: myocardial necrosis or reversible myocardial depression? Intensive Care Med 27(6):959-961, 2001.
44. Bogle RG, McLean PG, Ahluwalia A, Vallance P: Impaired vascular sensitivity to nitric oxide in the coronary microvasculature after endotoxaemia. Br J Pharmacol 130(1):118-124, 2000.
45. Madorin WS, Rui T, Sugimoto N, Handa O, Cepinskas G, Kvietys PR: Cardiac myocytes activated by septic plasma promote neutrophil transendothelial migration: role of platelet-activating factor and the chemokines LIX and KC. Circ Res 94(7):944-951, 2004.
46. Tjardes T, Neugebauer E: Sepsis research in the next millennium: concentrate on the software rather than the hardware. Shock 17(1):1-8, 2002.
47. Hoyer D, Friedrich H, Zwiener U, Pompe B, Baranowski R, Werdan K, Mü ller-Werdan U, Schmidt H: Prognostic impact of autonomic information flow in multiple organ dysfunction syndrome patients. Int J Cardiol 108(3): 359-369, 2006.
48. Sharshar T, Gray F, Lorin de la Grandmaison G, Hopkinson NS, Ross E, Dorandeu A, Orlikowski D, Raphael JC, Gajdos P, Annane D: Apoptosis of neurons in cardiovascular autonomic centres triggered by inducible nitric oxide synthase after death from septic shock. Lancet 362(9398):1799-1805, 2003.
49. Tateishi Y, Oda S, Nakamura M, Watanabe K, Kuwaki T, Moriguchi T, Hirasawa H: Depressed heart rate variability is associated with high IL-6 blood level and decline in the blood pressure in septic patients. Shock 28(5):549-553, 2007.
50. Nogueira AC: Changes in plasma free fatty acid levels in septic patients are associated with cardiac damage and reduction in heart rate variability. Shock 29(3):342-348, 2008.
51. Zorn-Pauly K, Pelzmann B, Lang P, Mächler H, Schmidt H, Ebelt H,Werdan K, Koidl B, Müller-Werdan U: Endotoxin impairs the human pacemaker current If. Shock 28(6):655-661, 2007.
52. Gholami M, Mazaheri P, Mohamadi A, Dehpour T, Safari F, Hajizadeh S, Moore KP, Mani AR: Endotoxemia is associated with partial uncoupling of cardiac pacemaker from cholinergic neural control in rats. Shock 37(2):219-227, 2012.
53. Tracey KJ: The inflammatory reflex. Nature 420(6917):853-859, 2002.
54. Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Eur Heart J 17(3): 354-381, 1996.
55. Raeburn CD: Vascular cell adhesion moleculeY1 expression is obligatory for endotoxin-induced myocardial neutrophil accumulation and contractile dysfunction. Surgery 130(2):319-325, 2001.
56. Vallet B: Bench-to-bedside review: endothelial cell dysfunction in severe sepsis: a role in organ dysfunction? Crit Care 7(2):130-138, 2003.
57. Skibsted S, Jones AE, Puskarich MA, Arnold R, Sherwin R, Trzeciak S, Schuetz P, Aird WC, Shapiro NI: Biomarkers of endothelial cell activation in early sepsis. Shock 39(5):427-432, 2013.
58. Furian T, Aguiar C, Prado K, Ribeiro RV, Becker L, Martinelli N, Clausell N, Rohde LE, Biolo A: Ventricular dysfunction and dilation in severe sepsis and septic shock: relation to endothelial function and mortality. J Crit Care 27(3):319e9-319e15, 2012.
59. Hartemink KJ, Groeneveld AB: The hemodynamics of human septic shock relate to circulating innate immunity factors. Immunol Invest 39(8):849-862, 2010.
60. Eichenholz PW, Eichacker PQ, Hoffman WD, Banks SM, Parrillo JE, Danner RL, Natanson C: Tumor necrosis factor challenges in canines: patterns of cardiovascular dysfunction. Am J Physiol 263(3 Pt 2):H668-H675, 1992.
61. Vincent JL, Bakker J, Marécaux G, Schandene L, Kahn RJ, Dupont E: Administration of anti-TNF antibody improves left ventricular function in septic shock patients. Results of a pilot study. Chest 101(3):810-815, 1992.
62. Niederbichler AD: An essential role for complement C5a in the pathogenesis of septic cardiac dysfunction. J Exp Med 203(1):53-61, 2006.
63. Flynn A, Chokkalingam Mani B, Mather PJ: Sepsis-induced cardiomyopathy: a review of pathophysiologic mechanisms. Heart Fail Rev 15(6):605-611, 2010.
64. Rossi MA, Celes MR, Prado CM, Saggioro FP: Myocardial structural changes in long-term human severe sepsis/septic shock may be responsible for cardiac dysfunction. Shock 27(1):10-18, 2007.
65. Liu S, Schreur KD: G proteinYmediated suppression of L-type Ca2+ current by interleukin-1 beta in cultured rat ventricular myocytes. Am J Physiol 268(2 Pt 1): C339-C349, 1995.
66. Zhong J: Reduced L-type calcium current in ventricular myocytes from endotoxemic guinea pigs. Am J Physiol 273(5 Pt 2):H2312-H2324, 1997.
67. Dong LW: Impairment of the ryanodine-sensitive calcium release channels in the cardiac sarcoplasmic reticulum and its underlying mechanism during the hypodynamic phase of sepsis. Shock 16(1):33-39, 2001.
68. Brinckerhoff CE, Matrisian LM: Matrix metalloproteinases: a tail of a frog that became a prince. Nat Rev Mol Cell Biol 3(3):207-214, 2002.
69. Khadour FH: Enhanced NO and superoxide generation in dysfunctional hearts from endotoxemic rats. Am J Physiol Heart Circ Physiol 283(3):H1108-H1115, 2002.
70. Lalu MM, Csont T, Schulz R: Matrix metalloproteinase activities are altered in the heart and plasma during endotoxemia. Crit Care Med 32(6):1332-1337, 2004.
71. Teng L: Matrix metalloproteinase-9 as new biomarkers of severity in multiple organ dysfunction syndrome caused by trauma and infection. Mol Cell Biochem 360(1-2):271-277, 2012.
72. Lalu MM, Gao CQ, Schulz R: Matrix metalloproteinase inhibitors attenuate endotoxemia induced cardiac dysfunction: a potential role for MMP-9. Mol Cell Biochem 251(1-2):61-66, 2003.
73. Hoffmann U: Matrix-metalloproteinases and their inhibitors are elevated in severe sepsis: prognostic value of TIMP-1 in severe sepsis. Scand J Infect Dis 38(10):867-872, 2006.
74. Lorente L: Matrix metalloproteinase-9,-10, and tissue inhibitor of matrix metalloproteinases-1 blood levels as biomarkers of severity and mortality in sepsis. Crit Care 13(5):R158, 2009.
75. Khan SA: Nitric oxide regulation of myocardial contractility and calcium cycling: independent impact of neuronal and endothelial nitric oxide synthases. Circ Res 92(12):1322-1329, 2003.
76. Kumar A: Role of nitric oxide and cGMP in human septic serum-induced depression of cardiac myocyte contractility. Am J Physiol 276(1 Pt 2):R265-R276, 1999.
77. Ishida H: Peroxynitrite-induced cardiac myocyte injury. Free Radic Biol Med 20(3):343-350, 1996.
78. Xie YW, Kaminski PM, Wolin MS: Inhibition of rat cardiac muscle contraction and mitochondrial respiration by endogenous peroxynitrite formation during posthypoxic reoxygenation. Circ Res 82(8):891-897, 1998.
79. Xu C: Mitochondrial nitric oxide synthase participates in septic shock myocardial depression by nitric oxide overproduction and mitochondrial permeability transition pore opening. Shock 37(1):110-115, 2012.
80. Exline MC, Crouser ED: Mitochondrial mechanisms of sepsis-induced organ failure. Front Biosci 13:5030-5041, 2008.
81. Suliman HB, Carraway MS, Piantadosi CA: Postlipopolysaccharide oxidative damage of mitochondrial DNA. Am J Respir Crit Care Med 167(4):570-579, 2003.
82. Larche J: Inhibition of mitochondrial permeability transition prevents sepsisinduced myocardial dysfunction and mortality. J Am Coll Cardiol 48(2): 377-385, 2006.
83. Piel DA: Mitochondrial resuscitation with exogenous cytochromec in the septic heart. Crit Care Med 35(9):2120-2127, 2007.
84. Brealey D: Association between mitochondrial dysfunction and severity and outcome of septic shock. Lancet 360(9328):219-223, 2002.
85. Piel DA, Deutschman CS, Levy RJ: Exogenous cytochrome C restores myocardial cytochrome oxidase activity into the late phase of sepsis. Shock 29(5): 612-616, 2008.
86. Rudiger A, Singer M: Mechanisms of sepsis-induced cardiac dysfunction. Crit Care Med 35(6):1599-1608, 2007.
87. Lancel S: Ventricular myocyte caspases are directly responsible for endotoxininduced cardiac dysfunction. Circulation 111(20):2596-2604, 2005.
88. Neviere R: Caspase inhibition prevents cardiac dysfunction and heart apoptosis in a rat model of sepsis. Am J Respir Crit Care Med 163(1):218-225, 2001.
89. Crouser E: A rare glimpse behind the mask of sepsis-induced organ failures provides hope for an eventual cure. AmJ Respir Crit CareMed 187(5):460-462, 2013.
90. Baumgarten G: Toll-like receptor 4, nitric oxide, and myocardial depression in endotoxemia. Shock 43-49, 2006.
91. Panaro MA: Toll-like receptor 4 mediates LPS-induced release of nitric oxide and tumor necrosis factor-alpha by embryonal cardiomyocytes: biological significance and clinical implications in human pathology. Curr Pharm Des 16(7):766-774, 2010.
92. Zhu X: Toll-like receptor 2 activation by bacterial peptidoglycan- associated lipoprotein activates cardiomyocyte inflammation and contractile dysfunction. Crit Care Med 35(3):886-892, 2007.
93. Knuefermann P: Bacterial DNA induces myocardial inflammation and reduces cardiomyocyte contractility: role of Toll-like receptor 9. Cardiovasc Res 78(1):26-35, 2008.
94. Rolli J: Bacterial flagellin triggers cardiac innate immune responses and acute contractile dysfunction. PLoS One 5(9):e12687, 2010.
95. Gao M: Toll-like receptor 3 plays a central role in cardiac dysfunction during polymicrobial sepsis. Crit Care Med 40(8):2390-2399, 2012.
96. Opal SM: Effect of eritoran, an antagonist of MD2-TLR4, on mortality in patients with severe sepsis: the ACCESS randomized trial. JAMA 309(11): 1154-1162.
97. Kregel KC: Heat shock proteins: modifying factors in physiological stress responses and acquired thermotolerance. J Appl Physiol 92(5):2177-2186, 2002.
98. Chen HW: Heat shock pretreatment prevents cardiac mitochondrial dysfunction during sepsis. Shock 20(3):274-279, 2003.
99. Stuart RA, Cyr DM, Neupert W: HSP70 in mitochondrial biogenesis: from chaperoning nascent polypeptide chains to facilitation of protein degradation. Experientia 50(11-12):1002-1011, 1994.
100. Meng X, Harken AH: The interaction between HSP70 and TNF-alpha expression: a novel mechanism for protection of the myocardium against post-injury depression. Shock 17(5):345-353, 2002.
101. Leentjens J: Immunotherapy for the adjunctive treatment of sepsis: from immunosuppression to immunostimulation. Time for a paradigm change? Am J Respir Crit Care Med 187(12):1287-1293, 2013.
102. Borlaug BA, Kass DA: Ventricular-vascular interaction in heart failure. Heart Fail Clin 4(1):23-36, 2008.
103. Torrent-Guasp F: The structure and function of the helical heart and its buttress wrapping. I the normal macroscopic structure of the heart. Semin Thorac Cardiovasc Surg 13(4):301-319, 2001.
104. Buckberg G: Ventricular torsion and untwisting: further insights into mechanics and timing interdependence: a viewpoint. Echocardiography 28(7):782-804.
105. Sanderson JE, Fraser AG: Systolic dysfunction in heart failure with a normal ejection fraction: echo-Doppler measurements. Prog Cardiovasc Dis 49(3): 196-206, 2006.
106. Helle-Valle T: New noninvasive method for assessment of left ventricular rotation: speckle tracking echocardiography. Circulation 112(20):3149-3156, 2005.
107. Basu S: Two-dimensional speckle tracking imaging detects impaired myocardial performance in children with septic shock, not recognized by conventional echocardiography. Pediatr Crit Care Med 2011.
108. Croce P: The four postulates of Robert Koch. Riv Biol 89(2):275-278, 1996.